Pancreatic cancer is a major cause of cancer-associated mortality, with a dismal overall
prognosis that has remained virtually unchanged for many decades. Currently, prevention or …

The overall 5-year survival for pancreatic cancer has changed little over the past few
decades, and pancreatic cancer is predicted to be the second leading cause of cancer …

Pancreatic cancer is one of the leading causes for cancer-related deaths in the United
States. Majority of patients present with unresectable or metastatic disease. For those that …

Pancreatic ductal adenocarcinoma is one of the most aggressive human malignancies, with
an overall 5-year survival rate of less than 4%. On the molecular level, an increasing number …

Pancreatic cancer is a disease with a high mortality rate and short survival, as a result of the
high incidence of metastatic disease at diagnosis, the fulminant clinical course and the lack …

Pancreatic adenocarcinoma is the most lethal of the solid tumors and the fourth leading
cause of cancer-related death in North America. Most patients present with locally advanced …

This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

Patients with pancreatic cancer normally present with advanced disease that is lethal and
notoriously difficult to treat. Survival has not improved dramatically despite routine use of …

Pancreatic cancer is the fourth leading cause of cancer-related death in the United States,
with increasing incidence. The mortality rate of pancreatic cancer is rising rapidly, and is …

In the last decade, continued efforts in pancreas cancer research have led to the
development of new, more effective therapies. Additionally, progress in understanding the …